Genomics Meets Big Pharma: How Drug Companies are Betting on Pharmacogenomics
The advent of pharmacogenomics in drug development heralds a paradigm shift within the pharmaceutical sector. This evolution is driven by the increasing prominence…
The advent of pharmacogenomics in drug development heralds a paradigm shift within the pharmaceutical sector. This evolution is driven by the increasing prominence…
Did you know that 16.8% of U.S. patients are exposed to multiple drugs with available pharmacogenomic guidelines1? This statistic highlights the pivotal role…
As early as 2011, the potential of big data science in healthcare was foreseen as transformative for the next decade1. This prophecy has…
Imagine if your DNA could show you the perfect drug for you. This idea is at the core of pharmacogenomics. It’s changing medicine…
Pharmacogenomics, the confluence of pharmacology and genomics, is poised to transform vaccine development and efficacy. It leverages genetic profiling to create vaccine therapies…
Did you know that without urgent action, antibiotic resistance could lead to over 10 million deaths annually? This alarming figure highlights the global…
Adverse drug reactions (ADRs) pose a substantial challenge within the pharmaceutical sector, with over 106,000 fatalities annually in the United States, according to…
“The future of medicine is personalized, predictive, and preventive.” – Dr. Francis Collins, Director of the National Institutes of Health1 Pharmacogenomics, a discipline…
Despite the rapid evolution of genetic technologies, the integration of genomic insights to alleviate health disparities in underprivileged communities remains a pressing area…
The Institute of Medicine reveals that one-third of the U.S. population grapples with persistent pain, underscoring a critical public health issue that necessitates…
End of content
End of content
Join Our Insider’s Circle! Stay up to Date with the latest in PGx